What Is in the Literature.

Q3 Medicine

Journal of Clinical Neuromuscular Disease Pub Date : 2022-03-01 DOI:10.1097/CND.0000000000000399

Mark B Bromberg

引用次数: 0

Abstract

Abstract: This issue of What Is in the Literature focuses on articles on amyotrophic lateral sclerosis over the past year. Amyotrophic lateral sclerosis remains a challenging disorder with progression to death. Within the past year, a phase 2 trial of a drug combination showed slowing in the rate of progression. While awaiting a phase 3 trial or approval by the Food and Drug Administration, selected articles that aid the diagnosis, contribute to care, or add to general knowledge about the disease are reviewed.

查看原文本刊更多论文

文学作品里有什么?

摘要:本期《什么是文献》聚焦于过去一年有关肌萎缩性侧索硬化症的文章。肌萎缩性侧索硬化症仍然是一个具有挑战性的疾病进展到死亡。在过去的一年里，一种药物组合的二期试验显示进展速度有所放缓。在等待第三阶段试验或食品和药物管理局批准的过程中，筛选有助于诊断、有助于护理或增加对疾病的一般知识的文章进行审查。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Neuromuscular Disease Medicine-Medicine (all)

CiteScore

1.60

自引率

0.00%

发文量

期刊介绍： Journal of Clinical Neuromuscular Disease provides original articles of interest to physicians who treat patients with neuromuscular diseases, including disorders of the motor neuron, peripheral nerves, neuromuscular junction, muscle, and autonomic nervous system. Each issue highlights the most advanced and successful approaches to diagnosis, functional assessment, surgical intervention, pharmacologic treatment, rehabilitation, and more.